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Abstract 19 
The rhoptries are key secretory organelles from apicomplexan parasites that contain proteins 20 
involved in invasion and modulation of the host cell. Some rhoptry proteins are restricted to the 21 
posterior bulb (ROPs) and others to the anterior neck (RONs). As many rhoptry proteins have been 22 
shown to be key players in Toxoplasma invasion and virulence, it is important to identify, 23 
understand and characterize the biological function of the components of the rhoptries. In this 24 
report, we identified putative novel rhoptry candidate genes by identifying Toxoplasma genes with 25 
similar cyclical expression profiles as known rhoptry protein encoding genes across its cell cycle. 26 
Using this approach we identified two new rhoptry bulb (ROP47 and ROP48) and one new rhoptry 27 
neck protein (RON12). ROP47 is secreted and traffics to the host cell nucleus, RON12 was not 28 
detected at the moving junction during invasion. Deletion of ROP47 or ROP48 in a type II strain 29 
did not show major influence in in vitro growth or virulence in mice.  30 
 31 
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  33 
1. Introduction 34 
Toxoplasma gondii is a highly successful parasite infecting approximately 30% of people 35 
worldwide and is the second largest cause of death due to foodborne illness in the United States 36 
(Scallan et al., 2011). Toxoplasmosis can be fatal in the unborn fetus and in immunosuppressed 37 
individuals if the disease is not recognized and treated early, in contrast to immunocompetent 38 
patients in whom it is mainly self-limited (Montoya and Liesenfeld, 2004; Scallan et al., 2011). 39 
Toxoplasma resides within a non-fusogenic parasitophorous vacuole and has three apical secretory 40 
organelles: the dense granules, micronemes and rhoptries. Rhoptries are club-shaped organelles 41 
divided into two distinct compartments, the posterior bulb and the more anterior duct (neck) 42 
through which rhoptry proteins are secreted. Proteins derived from the rhoptry secretory organelles 43 
are crucial for the invasion and survival of apicomplexan parasites within host cells and thus 44 
rhoptry protein targeting is a vital process for Toxoplasma. Some rhoptry proteins are restricted to 45 
the bulb (ROPs) and others to the neck (RONs). The role of rhoptries in the invasion process, 46 
virulence and/or host cell modulation has been well documented, although the molecular 47 
mechanisms remain only partially understood. RONs 2, 4, 5 and 8 have been shown to be involved 48 
in parasite invasion of the host cell (Besteiro et al., 2009; Straub et al., 2009); ROP16 activates the 49 
transcription factors STAT3 and STAT6 (Saeij et al., 2007; Yamamoto et al., 2009; Ong et al., 50 
2010); ROP38 downregulates Mitogen Activated Protein Kinase (MAPK) pathway activation 51 
(Peixoto et al., 2010); and ROP5 and ROP18 act jointly to block immunity-related GTPase (IRG) 52 
mediated clearance of the parasite by the host cell (Behnke et al., 2012; Fleckenstein et al., 2012; 53 
Niedelman et al., 2012). Once rhoptry proteins are secreted into the host cell cytosol they traffic to 54 
distinct cellular destinations. For example, ROP16 and the rhoptry protein phosphatase 2 C (PP2C-55 
hn) carry a nuclear localization signal (NLS), which mediates their trafficking to the host nucleus 56 
(Gilbert et al., 2007; Saeij et al., 2007), ROP5 and ROP18, following secretion into the host cell, 57 
traffic back to the outside of the parasitophorous membrane vacuole (PVM) via an arginine-rich 58 
amphipathic helix domain that is essential for this localization (Reese and Boothroyd, 2009; 59 
Fentress et al., 2012). Other rhoptry proteins, such as Toxofilin, remain in the host cell cytosol upon 60 
secretion (Lodoen et al., 2010). 61 
Rhoptry proteins contain a classic eukaryotic signal peptide for entrance into the secretory 62 
pathway and are trafficked from the endoplasmic reticulum through the Golgi by a conserved 63 
pathway before being packaged into the apically located secretory organelles (Sadak et al., 1988; 64 
Bradley and Boothroyd, 1999; Bradley et al., 2004; Carey et al., 2004; Hajj et al., 2006b, 2007; 65 
Turetzky et al., 2010). N-terminal pro-domains have been implicated in rhoptry protein sorting and 66 
indeed several rhoptry proteins exhibit N-terminal processing. However, the failure to remove the 67 
pro-domain does not seem to disrupt targeting (Bradley et al., 2002; Miller et al., 2003; Turetzky et 68 
al., 2010). Other rhoptry proteins do not appear to be processed and the mechanism by which they 69 
are targeted to the rhoptries is unknown. Additionally, any soluble protein recombinantly fused to a 70 
signal peptide is delivered to the dense granules by default (Joiner and Roos, 2002). Therefore, 71 
motifs that mediate trafficking of proteins to the rhoptry organelles are insufficiently defined, or 72 
insufficiently specific, to allow genome-wide identification of rhoptry proteins. 73 
Proteomic and genomic approaches have been widely used to identify the contents of the 74 
rhoptries of apicomplexan parasites (Hoppe et al., 2000; Bradley et al., 2005; Peixoto et al., 2010; 75 
Marugán-Hernández et al., 2011; Reid et al., 2012; Oakes et al., 2013). A proteomic study of 76 
Toxoplasma rhoptry contents led to the identification of 38 rhoptry proteins (Bradley et al., 2005). 77 
Twenty of these proteins were shown to localize to the rhoptry organelles, 11 to the rhoptry bulb 78 
and nine to the rhoptry neck (Bradley et al., 2005; Taylor et al., 2006; Gilbert et al., 2007; 79 
Proellocks et al., 2009; Straub et al., 2009; Peixoto et al., 2010; Lamarque et al., 2012). As 80 
expected, several previously known rhoptry proteins were readily detected in this proteomic 81 
analysis. However, TgNHE2 and TgSUB2, previously characterized as rhoptry proteins, were 82 
missed. The absence of these known rhoptry proteins is likely due to limitations of the technique, 83 
such as size cut-off or low amounts of protein.  84 
Because several rhoptry proteins, such as the aforementioned ROP5, ROP16, ROP18 and 85 
ROP38, contain kinase-like domains (Hajj et al., 2006a; Peixoto et al., 2010), another study 86 
exploited a phylogenomic approach to characterize the Toxoplasma kinome, defining a 44-member 87 
family of kinase-like rhoptry proteins based on sequence similarities, including all previously 88 
reported kinase-like rhoptry proteins (Peixoto et al., 2010). To evaluate the accuracy of these 89 
predictions, nine of the identified kinase-like rhoptry proteins were confirmed to localize to the 90 
rhoptries, whereas two (ROP21 and ROP22) did not but were still annotated as rhoptry proteins. 91 
Surprisingly, the overlap between these two studies is relatively small, with only 11 genes found in 92 
common, which emphasizes the complementarity of different methodologies and the likelihood that 93 
there are still rhoptry proteins yet to be identified. 94 
Previous characterization of the cell cycle transcriptome of Toxoplasma covering 12 h post-95 
synchronization and nearly two tachyzoite replication cycles showed that the mRNA levels of 96 
proteins secreted from the rhoptry organelles display a cyclical expression profile, reaching peak 97 
levels in late S phase/early mitosis followed by a rapid and dramatic decline of these transcripts in 98 
early G1, before peaking again in the next S phase (Behnke et al., 2010). Inner membrane complex 99 
(IMC) mRNAs presented a very similar cyclical expression profile. Microneme mRNAs were offset 100 
by 1–2 h from rhoptry mRNAs and defined a distinct temporal class. By contrast, dense granule 101 
mRNAs largely were not regulated in the tachyzoite cell cycle.  102 
Here we combined in silico and in vivo methods to identify novel rhoptry proteins likely to 103 
be involved in parasite modulation of host cells and found two novel rhoptry bulb proteins and one 104 
novel rhoptry neck protein.  105 
 106 
2. Materials and methods 107 
2.1. Parasites and cell lines 108 
Parasites were maintained in vitro by serial passage on monolayers of human foreskin 109 
fibroblasts (HFFs) at 37°C in 5% CO2. HFFs were grown in DMEM supplemented with 10% FBS. 110 
C57BL6/J mouse embryonic fibroblasts (MEFs) were a gift from A. Sinai (University of Kentucky 111 
College of Medicine, Lexington, KY, USA) and were grown in HFF media supplemented with 10 112 
mM HEPES, 1 mM sodium pyruvate and 1X non-essential amino acids.  113 
 114 
2.2. Identification of candidate genes 115 
For identification of new rhoptry protein coding genes, cell cycle transcriptome data of the 116 
Toxoplasma gondii during synchronized growth in human foreskin fibroblasts (HFFs) deposited at 117 
Gene Expression Omnibus (GEO)with accession number GSE19092 were used (Behnke et al., 118 
2010). The data were normalized using Robust Multi Array (RMA) algorithm using Affymetrix 119 
Expression Console Software version 1.3.1, and all background values less than 6.5 were set to 6.5. 120 
Genes with an expression value of less than 6.5 in 12 or more samples where removed from the 121 
analysis. K-means clustering of each duplicated sample (time-point) was performed using the 122 
default distance metric (Pearson correlation) and a maximum number of 50, 45, 40, 35, 30, 25, 20, 123 
12 and 10 clusters in Multiple Array Viewer 4.6. The cluster with the largest number of previously 124 
annotated rhoptry proteins was chosen for further analysis. The candidate genes were chosen using 125 
the following criteria: i) contained a predicted signal peptide, ii) had unannotated function and iii) 126 
unknown subcellular localization. 127 
 128 
2.3. Gene tagging  129 
Genomic sequences were obtained from the ToxoDB database (Version 8.0, ToxoDB.org) 130 
(Kissinger et al., 2003). For endogenous gene tagging (Huynh and Carruthers, 2009), primers were 131 
designed to amplify 1 - 3 kb of the predicted 3’ ends of genes. For heterologous expression of 132 
ROP47, the coding regions of TGME49_261740, together with putative promoter (~1500 bp 133 
upstream of ATG start codon) were amplified by PCR. All forward primers contained the 5’-134 
CACC-3’ sequence required to perform directional TOPO cloning in pENTR/D-TOPO (Invitrogen, 135 
USA) and all reverse primers contained the hemagglutinin (HA) tag sequence followed by a stop 136 
codon (Table 1). HA-tagged sequences were cloned in vector pTKOatt by Gateway Recombination 137 
Cloning Technology (Invitrogen, USA). For endogenous gene tagging, the resulting vectors were 138 
linearized using a restriction enzyme with a unique restriction site within the cloned fragment. 139 
Linearized vector was transfected into RHΔhxgprtΔku80 (a gift from V. Carruthers, University of 140 
Michigan, Ann Arbor, MI, USA) parasites by electroporation. For heterologous expression of 141 
ROP47, vector was not linearized and was transfected into RHΔhxgprt. Electroporation was done in 142 
a 2 mm cuvette (Bio-Rad Laboratories, USA) with 2 mM ATP (MP Biomedicals, USA) and 5 mM 143 
glutathione (EMD, Germany) in a Gene Pulser Xcell (Bio-Rad Laboratories), with the following 144 
settings: 25 µFD, 1.25 kV, ∞Ω. Stable integrants were selected in media with 50 µg/ml of 145 
mycophenolic acid (Axxora, USA) and 50 µg/ml of xanthine (Alfa Aesar, USA) and cloned by 146 
limiting dilution. The correct tagging of each gene was confirmed by PCR, using a primer upstream 147 
of the plasmid integration site and a primer specific for the HA tag and/or by immunofluorescence 148 
(IF) analysis. 149 
 150 
2.4. IF analysis 151 
Parasites were allowed to invade cells on coverslips and incubated for 16 – 24 h. The cells 152 
were then fixed with 3% (vol/vol) formaldehyde in PBS for 20 min at room temperature and 153 
blocked in PBS with 3% (wt/vol) BSA and 5% (vol/vol) goat serum. Coverslips were incubated 154 
with primary antibody for 1 h at room temperature or overnight at 4°C, and fluorescent secondary 155 
antibodies and Hoechst dye were used for antigen and DNA visualization, respectively. Coverslips 156 
were mounted on a glass slide with Vectashield (Vector Laboratories, USA), and photographs were 157 
taken using NIS-Elements software (Nikon, Japan) and a digital camera (CoolSNAP EZ; Roper 158 
Industries, USA) connected to an inverted fluorescence microscope (model eclipse Ti-S; Nikon). To 159 
determine seroconversion, peripheral blood serum was used as a primary antibody. For co-160 
localization experiments, GFP-expressing parasites were fixed with methanol or 3% (vol/vol) 161 
formaldehyde. For moving junction staining, this standard IF protocol was modified slightly. 162 
Parasites were added to HFFs on coverslips, spun down to bring them into contact with host cells, 163 
and allowed to attach to and invade host cells for 5 min at 37°C. Unattached parasites were washed 164 
off with PBS, and cells were fixed with 3% (vol/vol) formaldehyde in PBS for 20 min at room 165 
temperature, blocked in PBS with 5% (vol/vol) FBS and 5% (vol/vol) normal goat serum for 1 – 2 h 166 
at room temperature, and permeabilized by incubation in PBS with 0.2% (wt/vol) saponin at 37°C 167 
for 20 min.  168 
 169 
2.5. Antibodies  170 
Recombinant ROP47 peptide antigen was generated by PCR amplification of sequences 171 
immediately downstream of the predicted ROP47 signal peptide and immediately upstream of the 172 
ROP47 stop codon from Pru∆hxgprt genomic DNA. The amplicon was cloned in frame into 173 
pET102/D-TOPO (Invitrogen), creating a Thioredoxin-ROP47-V5-His6 construct. This protein was 174 
expressed in BL21 Star (Invitrogen) cells and purified on a Ni-NTA column (Invitrogen) eluted 175 
with 250 mM imidazole and dialyzed under native conditions according to the manufacturer’s 176 
directions. Rabbit polyclonal antibodies (Covance, USA) were raised against the purified peptide 177 
antigen. Antibodies were affinity purified from the ROP47 antiserum with Affi-Gel 10 resin (Bio-178 
Rad) covalently coupled to the antigen peptide and eluted with 100 mM Glycine, pH 2.5, then 179 
immediately neutralized with 1 M Tris pH 8.0. The eluate was subsequently incubated with Affi-180 
Gel 10 resin covalently coupled to a Thioredoxin-V5-His6 peptide that was expressed and purified 181 
as above to remove antibodies in the serum reacting against thioredoxin and the epitope tags. The 182 
flow-through was collected, tested for specificity and used for immunogenic assays. 183 
Antibodies against HA (Roche), Toxoplasma surface antigen (SAG)-1 (DG52, (Burg et al., 184 
1988)), Toxoplasma rhoptry protein ROP1 (Tg49; (Ossorio et al., 1992)), Toxoplasma dense 185 
granule protein GRA7 (Dunn et al., 2008), Toxoplasma rhoptry neck protein RON4 (generously 186 
provided by P. Bradley, University of California, Los Angeles, CA, USA), Toxoplasma inner 187 
membrane complex proteins IMC1 and MLP1 (generously provided by M.J. Gubbels, Boston 188 
College, Boston, MA, USA) and mouse TGTP (A-20; Santa Cruz Biotechnology, USA) were used 189 
in the IF assay. IF secondary antibodies were coupled with Alexa Fluor 488 or Alexa Fluor 594 190 
(Invitrogen).  191 
 192 
2.6. Western blot 193 
Parasites were syringe lysed from infected HFFs with lysis buffer, boiled for 5 min and 194 
subjected to 10% SDS-PAGE. Proteins were transferred to a polyvinylidene difluoride membrane, 195 
which was blocked in PBS/0.1% Tween-20/5% non-fat dry milk and incubated with primary and 196 
secondary antibodies. The blot was incubated with a luminal-based substrate (Immun-Star 197 
WesternC; Bio-Rad Laboratories) and chemiluminescence was detected using a charge-coupled 198 
device camera (Chemidoc XRS; Bio-Rad Laboratories). The bands were visualized using Quantity 199 
One 1-D analysis software. 200 
 201 
2.7. Generation of gene knockouts (KOs) 202 
The 5’ and 3’ flanking regions of the genes to be knocked out were cloned in pTKO2 203 
(Rosowski et al., 2011) around the hypoxanthine-xanthine-guanine ribosyl transferase (HXGPRT) 204 
selectable marker using Multisite Gateway Pro 3-Fragment Recombination (Invitrogen). Flanking 205 
regions (5’ and 3’) of TGME49_201860, TGME49_218270 and TGME49_261740 were cloned 206 
from type II genomic DNA. Primers contained att recombination sites (denoted in primer sequence 207 
with italics, Table 1) and amplified ≈2 kb upstream of the start codon and downstream of the stop 208 
codon. These flanking regions were then cloned around the HXGPRT selectable marker flanked by 209 
5’ and 3’ untranslated region (UTRs) from dihydrofolate reductase (DHFR), as previously described 210 
(Rosowski et al., 2011). Before transfection, the KO vector was linearized. PruΔhxgprtΔku80 (a gift 211 
from D. Bzik, Dartmouth Medical School, Lebanon, NH, USA) parasites were transfected with the 212 
KO construct by electroporation, and stable integrants were selected and cloned by limiting 213 
dilution, as described in Section 2.3. PCR with a forward primer upstream of the 5’ flanking region 214 
(P1) and a reverse primer within the HXGPRT cassette (P2) confirmed the disruption in the desired 215 
loci (Supplementary Fig. S1A). Additionally, PCR was performed to confirm the inability to 216 
amplify the target genes (P3 and P4) (Supplementary Fig S1A). 217 
 218 
2.8. Plaque assays  219 
For the plaque assays, 100–500 parasites per well were added to monolayers of MEFs 220 
seeded the day before and either previously stimulated with 1000 U/mL of mouse IFNγ or left 221 
unstimulated for 24 h before infection in a 24 well plate in MEF media. Infections were then 222 
incubated for 5 days at 37°C and the number of plaques was counted using a microscope.  223 
 224 
2.9. Animal infections 225 
Six to 10 week old female C57BL/6J mice (The Jackson Laboratory, USA) were used in all 226 
experiments. For  i.p. infection, tachyzoites were grown in vitro and extracted from host cells by 227 
passage through a 30-gauge needle, washed twice in PBS and quantified with a hemocytometer. 228 
Parasites were diluted in PBS and mice were inoculated i.p. with 500 tachyzoites of each strain (in 229 
100 µL) using a 28-gauge needle. For oral infection, brain homogenate of chronically infected mice 230 
was stained with dolichos biflorus-FITC (Vector Laboratories) and cysts were enumerated by 231 
microscopy. The mice were orally gavaged with 1000 cysts. All of the animals were monitored 232 
daily and weighed three times per week. Peripheral blood serum was collected on days 7 and 30 of 233 
the experiment and the levels of IFNγ  were determined using commercially available ELISA kits, 234 
according to the manufacturer’s protocol (eBioscience, USA). The Massachusetts Institute for 235 
Technology, USA, Committee on Animal Care approved all protocols. All mice were maintained 236 
under specific pathogen-free conditions, in accordance with institutional and federal regulations. 237 
 238 
3. Results and Discussion 239 
3.1. Identification of novel rhoptry proteins 240 
Previous characterization of the Toxoplasma cell cycle transcriptome showed that the 241 
mRNA levels of rhoptry encoding genes display the same cyclical expression profile (Behnke et al., 242 
2010). We hypothesized that unidentified rhoptry encoding genes would show a similar expression 243 
profile. Genes were identified that showed the same expression pattern as established rhoptry 244 
encoding genes by performing K-means clustering of 13 duplicate samples spanning 12 h post-245 
thymidine release into the tachyzoite cell cycle. The cluster with the largest number of previously 246 
annotated rhoptry protein encoding genes (67 out of 75 annotated rhoptry encoding genes were 247 
expressed above background and were present on the Toxoplasma array; Supplementary Table S1) 248 
was chosen for further analysis (Table 2, Supplementary Fig. S2). This cluster contained 190 unique 249 
genes, of which 45 encoded proteins annotated as rhoptries (out of 67 possible genes) and four 250 
encoded IMC proteins. Thirty-one out of these 45 have been previously confirmed to localize to the 251 
rhoptry organelles.  252 
The Toxoplasma genome is predicted to encode 8127 genes, 1920 of which have a signal 253 
peptide (23.4%). Our analysis imposed no explicit selection for genes coding for proteins with 254 
signal peptide sequences; however, the resulting list is enriched (65 genes with a predicted signal 255 
peptide out of 190, P = 0.0003, Hypergeometric distribution) in signal-peptide-containing proteins 256 
(34%). 257 
Interestingly, 22 out of the 75 tachyzoite rhoptry proteins encoding genes never clustered 258 
with the remainder of the rhoptries (Supplementary Table S1). Two of these genes (RON2L1 and 259 
BRP1 (Schwarz et al., 2005; Fritz et al., 2012)) encode bradyzoite- or sporozoite-specific rhoptry 260 
proteins and six encode confirmed tachyzoite rhoptries (ROP9, ROP38, ROP39, TgARO, Toxolysin 261 
1 and Subtilisin 2). According to the cell cycle expression data (Behnke et al., 2010), ROP9, ROP38 262 
and ROP39 do not display an obvious cyclical expression profile. In addition, ROP9 was shown to 263 
be secreted with micronemal proteins, in a calcium-dependent manner (Kawase et al., 2007). The 264 
cellular localization of the proteins encoded by the other 14 genes annotated as rhoptry protein 265 
genes (Supplementary Table S1) was never confirmed by IF and it is therefore possible that these 266 
are not localized to the rhoptries.  267 
These results underscore the relevance of our approach and strongly suggest that our rhoptry 268 
protein cluster might contain many of the remainder of the unidentified rhoptry protein-encoding 269 
genes of tachyzoites. To identify new putative rhoptry protein encoding genes that could modulate 270 
host cell functions, we chose eight genes that encoded a protein with a predicted signal peptide, 271 
unannotated function and unknown subcellular localization from within our rhoptry cluster. The 272 
eight candidate genes are described in Table 2, highlighted in grey, and all display the cyclic 273 
expression profile described above (Fig. 1).  274 
To determine the localization of the candidate gene products within the parasite, we 275 
genetically engineered Toxoplasma strains expressing an HA-tagged version of the candidate genes 276 
at their endogenous loci. We were unable to endogenously tag TGME49_261740 and therefore 277 
determined its localization by heterologous expression of a C-terminal HA-tagged copy of the 278 
candidate gene, including at least 1500 bp of the putative endogenous promoter. The correct tagging 279 
of each endogenously tagged gene was confirmed by PCR (Supplementary Fig. S3). IF analysis was 280 
performed on HFFs infected with each of the HA-tagged parasites. The staining pattern of four out 281 
of eight candidate gene products was unlike that of the secretory organelles and appeared to label 282 
the whole parasite (Supplementary Fig. S4). The genes whose labeling appeared consistent with that 283 
of the secretory organelles were TGME49_201860, TGME49_218270, TGME49_232020 and 284 
TGME49_261740 (Fig. 2A). Some characteristics of the proteins encoded by these genes  are 285 
described in Table 3.  286 
The product of TGME49_201860-HA appears to have a punctate distribution, present at 287 
both the posterior and the apical end of the parasite (Fig. 2A). TGME49_218270-HA seems to label 288 
the rhoptry bulb. We were unable to detect these two proteins using an anti-HA western blot, and 289 
therefore do not know whether they undergo post-transcriptional processing.  290 
TGME49_232020-HA localizes to the apical pole of the parasite, a labeling consistent with 291 
the rhoptry neck (Fig. 2A). This gene is predicted to encode a protein with no signal peptide in type 292 
II parasites. However, as first exon prediction is notoriously difficult, in type I and type III 293 
parasites, this protein is predicted have a signal peptide. Moreover, TGME49_232020 encodes a 294 
protein with a predicted molecular weight of 135  kDa. However, western blot analysis of the 295 
TGME49_232020-HA strain detected a band of approximately 40 kDa, instead of the predicted 135 296 
kDa (Supplementary Fig. S5). Indeed, several rhoptry proteins exhibit N-terminal processing and 297 
that is also probably the case for TGME49_232020. The rhoptry subtilisin TgSUB2 recognizes and 298 
cleaves after the consensus sequence SΦXE (Miller et al., 2003). There is a putative SUB2 299 
cleavage site (SPQE) between amino acids 968 and 971 of TGME49_232020. Cleavage at this site 300 
would generate a ~32 kDa tagged product, which could be consistent with the band observed. 301 
Longer exposures did not reveal a 135 kDa pro-protein, suggesting that the half-life of the pro-302 
protein is very short. 303 
TGME49_261740-HA appears to label the entire rhoptry organelle (Fig. 2A). Interestingly, 304 
TGME49_261740 is in the top five of the most highly expressed genes across the Toxoplasma cell 305 
cycle (Behnke et al., 2010) and is one of the most polymorphic Toxoplasma genes (Minot et al., 306 
2012). Anti-HA western blotting of this protein detected a band of approximately 15 kDa, 307 
consistent with the predicted size of 14 kDa (Supplementary Fig. S1B). 308 
These four proteins are conserved between Toxoplasma and Neospora (Table 3), but protein 309 
BLAST analysis did not reveal the presence of close (30% or more protein identity) homologues in 310 
other apicomplexans. Additionally, no known conserved domains were detected, giving no 311 
indication about the potential function of these proteins.  312 
 313 
3.2. TGME49_218270, TGME49_232020 and TGME49_261740 encode new rhoptry proteins 314 
To further confirm the localization of TGME49_201860, TGME49_218270, 315 
TGME49_232020 and TGME49_261740 within the parasite, we performed co-staining of each 316 
protein with a rhoptry bulb marker, ROP1, on intracellular parasites (Fig. 2A). TGME49_218270-317 
HA shows a perfect co-localization with ROP1.  318 
TGME49_201860-HA does not overlap with this rhoptry marker. To further investigate the 319 
cellular localization of this protein, we co-stained the TGME49_201860-HA expressing parasites 320 
with dense granule (GRA7) and inner membrane complex (IMC1 and MIP1-like protein-1 (MLP1)) 321 
markers (Fig. 2B). TGME49_201860-HA appears to partially overlap with GRA7. In addition, 322 
while it does not co-localize with IMC1, it co-localizes with MLP1, a protein that is present at the 323 
apical cap and basal complex of mature as well as budding daughter parasites (MJ Gubbels, 324 
personal communication).  325 
TGME49_232020-HA showed labeling of the apical pole anterior to the rhoptry bulb 326 
protein ROP1, as well as co-localization with RON4 staining (Fig. 2C), confirming rhoptry neck 327 
localization in intracellular parasites. Interestingly, TGME49_232020-HA does not localize to the 328 
moving junction in invading parasites (Fig. 2C). It was recently shown that RON9, RON10 and 329 
RON11, in contrast to the other RONs described to date, do not relocalize from the rhoptry neck to 330 
the moving junction during host invasion (Lamarque et al., 2012; Beck et al., 2013). 331 
TGME49_232020 localization also seems to be independent of the moving junction.  Similar to 332 
TGME49_232020, RON10 has a predicted signal peptide in its N-terminus but no known domains 333 
or motifs have been identified. In contrast, RON9 harbors several protein-protein interaction 334 
domains. The disruption of either RON9 or RON10 led to the retention of either protein in the 335 
endoplasmic reticulum (ER), suggesting an interaction between RON9 and RON10 during their 336 
trafficking through the secretory pathway on the way to the rhoptries. Whether TGME49_232020 337 
can interact with the RON9/RON10 complex or any other rhoptry neck protein in a similar fashion 338 
remains to be determined. TGME49_261740 co-localizes with ROP1 (Fig. 2B) and is also found in 339 
the nucleus of infected host cells (Fig. 2D). NLS Mapper (Kosugi et al., 2009) predicts that 340 
TGME49_261740 (ROP47) encodes a bipartite NLS with a score of 3.4. Moreover, this protein is 341 
predicted to have a size of 15 kDa and is probably able to diffuse through nuclear pores.  342 
Altogether, these results suggest that TGME49_261740 and TGME49_218270 encode new 343 
rhoptry bulb proteins, hereafter referred to as ROP47 and ROP48, respectively. TGME49_232020 344 
codes for a new rhoptry neck protein, from now on referred to as RON12.  345 
 346 
3.3. TGME49_201860 and ROP48 are not implicated in evasion of the IFNγ response 347 
To investigate the role of TGME49_201860, ROP47 and ROP48 in parasite biology, we 348 
removed these genes in the PruΔhxgprtΔku80 strain using double homologous recombination. PCR 349 
confirmed both the absence of the target gene coding sequences and the insertion of the hxgprt gene 350 
in the parasite genome. The deletion of ROP47 was confirmed by western blot (Supplementary Fig. 351 
S1B). Our attempts to generate a KO of RON12 in the PruΔhxgprtΔku80 strain have to date been 352 
unsuccessful. 353 
To determine a potential growth phenotype, monolayers of MEF were infected with 354 
PruΔhxgprtΔku80, Δtgme49_201860 or Δrop48 parasites, the parasites were allowed to grow for 5 355 
days, and then the areas of the plaques formed on the monolayers were quantified (Fig. 3A). 356 
PruΔhxgprtΔku80, Δtgme49_201860 and Δrop48 strains did not form significantly different sized 357 
plaques. These data indicate that deletion of TGME49_201860 or ROP48 has no major influence on 358 
in vitro Toxoplasma growth.  359 
It is well established that IFNγ is the main mediator of resistance against Toxoplasma 360 
(Suzuki et al., 1988). An important class of downstream effectors of this immune activation is the 361 
IFNγ-inducible immunity-related GTPases (IRGs), which belong to the dynamin family of GTPases 362 
and can cooperatively oligomerize to vesiculate membranes. The IRGs are able to disrupt the PVM 363 
and kill the parasite (Butcher et al., 2005). Recently, two rhoptry proteins were shown to mediate 364 
Toxoplasma evasion of the IFNγ−induced IRGs in murine cells (Fentress et al., 2010; Steinfeldt et 365 
al., 2010; Niedelman et al., 2012). To study a potential role of ROP48 and TGME49_201860 in 366 
Toxoplasma resistance to IFNγ and the IRGs, we measured the percentage of vacuoles coated with 367 
Irgb6 by IF in IFNγ-stimulated MEFs infected with PruΔhxgprtΔku80, Δtgme49_201860 or Δrop48. 368 
The percentage of coated vacuoles was approximately 50% in both Δtgme49_201860 and Δrop48 369 
and was not significantly different from that of the parental strain, PruΔhxgprtΔku80 (Fig. 3B). 370 
Although it is generally assumed that once the PVM is coated, it will eventually lead to killing of 371 
the parasite inside, it has also been shown that Toxoplasma can escape a coated vacuole and invade 372 
a new cell (Zhao et al., 2009). Therefore, to measure killing of Toxoplasma, a plaque loss assay was 373 
performed, as described in Niedelman et al., (2012). Briefly, 100 parasites were seeded on a 374 
monolayer of MEF, either previously stimulated for 24 h with IFNγ or left untreated, and the 375 
number of plaques that form after 5 days of growth was determined. The three strains had an 376 
average of ~30% plaque loss when comparing plaques formed on IFNγ-stimulated MEFs with 377 
unstimulated MEFs. This percentage of plaque loss was lower than the percentage of vacuoles 378 
coated with Irgb6, suggesting that some coated vacuoles can escape destruction by the IRGs. 379 
Overall, the results suggest that TGME49_201860 and ROP48 are not implicated in evading the 380 
IFNγ response in MEFs. Indeed, ROP5 and ROP18 were recently reported to mediate Toxoplasma 381 
evasion of the murine IFNγ response (Niedelman et al., 2012). These two proteins seem to 382 
determine the majority of strain differences in mouse IRG evasion, even for non-clonal strains for 383 
which virulence determinants have not been studied. However, neither ROP18 nor ROP5 markedly 384 
affect survival in IFNγ-activated human cells and it is reasonable to speculate that one or more 385 
still unidentified, secreted, potentially a rhoptry, protein could be involved in escaping IFNγ-386 
mediated killing in other host cell types. Whether this (these) protein(s) can be found within the 387 
rhoptry cluster will be the object of future studies.  388 
 389 
3.4. TGME49_201860, ROP47 and ROP48 are not implicated in Toxoplasma virulence in mice 390 
To examine the role of TGME49_201860, ROP47 and ROP48 on parasite virulence, we 391 
infected C57BL/6 mice by i.p. injection with 500 tachyzoites of PruΔhxgprtΔku80, 392 
Δtgme49_201860, Δrop47, Δrop48 or a heterologous control strain (Het) and assessed mouse 393 
morbidity (through monitoring of weight loss) and survival during the initial phase of infection 394 
(days 0-32) (Fig. 4A, B). Weight loss started at day 4 p.i. The mice reached their lowest weight 395 
between days 14 and 18 (~80% of their initial body weight) and did not regain their original weight. 396 
The survival of C57BL/6 mice infected with either strain did not show significant differences 397 
compared with PruΔhxgprtΔku80 infected mice (P = 0.9060, Log-rank Mantel-Cox test). 398 
Seroconversion was examined at day 30 p.i..and all the animals tested seropositive (data not 399 
shown). The level of IFNγ in peripheral blood serum was measured at day 7 and day 30 p.i. (Fig. 400 
4D). IFNγ levels were higher at day 7 than day 30 and similar for all the strains. Prior to infection, 401 
animals did not display detectable levels of IFNγ. At day 35 p.i., the surviving mice were sacrificed 402 
and the number of brain cysts per mouse was determined (Fig. 4C). The numbers of cysts generated 403 
by the Δtgme49_201860, Δrop47 and Δrop48 parasites were not significantly different from that of 404 
their parental strain. The number of brain cysts observed in the mice injected i.p. with the 405 
heterologous control strain was significantly lower (~1.6 fold, P = 0.0011, Student’s t-test) than that 406 
observed in mice infected with PruΔhxgprtΔku80 parasites. Accordingly, it was previously reported 407 
that PruΔku80::hxgprt exhibited lower cyst burdens than PruΔhxgprtΔku80 (Fox et al., 2011), which 408 
suggests the presence of HXGPRT might affect generation or viability of brain cysts. Additionally, 409 
we infected C57BL/6 mice by oral gavage with 1000 brain cysts of the same strains. We found no 410 
difference in mouse morbidity and survival (data not shown).  411 
Overall, the results suggest that TGME49_201860, ROP47 and ROP48 are not implicated in 412 
Toxoplasma virulence in mice. Interestingly, relatively few rhoptry proteins seem to have been 413 
investigated on their ability to affect virulence in the mouse model. Of the 10 proteins that were 414 
reported, ROP5, ROP16, ROP13, ROP18, RON8, RON9/10, TLN1, BRP1 and PP2C-hn (Saeij et 415 
al., 2006; Gilbert et al., 2007; Turetzky et al., 2010; Hajagos et al., 2011; Straub et al., 2011; 416 
Lamarque et al., 2012; Niedelman et al., 2012;), only four (RON8, ROP5, ROP16, ROP18) have an 417 
effect on mouse survival. However, mouse virulence is often tested in tachyzoites, the asexually 418 
reproducing form of the parasite, leaving out events that are restricted to the sexual life cycle of the 419 
parasite. Alternatively, the mouse model used may not be the optimal setting to reveal an essential 420 
role for such proteins in infection. For instance, a role in virulence could only be apparent in other 421 
intermediate hosts and/or when cysts are ingested naturally. Elucidation of this question will be 422 
extremely challenging due to the remarkable host range of Toxoplasma. 423 
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  625 
Figure legends 626 
 627 
Fig. 1. Identification of new Toxoplasma rhoptry proteins. The gene expression profile of the entire 628 
genome of Toxoplasma was compared with the cyclical gene expression profile of rhoptry genes 629 
throughout the cell cycle by performing clustering of duplicate samples spanning 12 h post-630 
synchronization (Supplementary Fig. S2). Shown are eight genes that displayed an expression 631 
profile signature similar to the rhoptry pattern and that were chosen for further analysis. The 632 
expression profile of ROP1 is also shown. 633 
 634 
Fig. 2. Cellular localization of C-terminally tagged genes. Human foreskin fibroblasts (HFFs) were 635 
infected with RH expressing hemagglutinin (HA)-tagged TGME49_201860, TGME49_218270 636 
(rop48), TGME49_232020 (ron12) or TGME49_261740 (rop47), fixed and stained with (A) α-HA 637 
and rhoptry protein marker α−ROP1, (B) α-HA and dense granule protein marker α-GRA7, α-HA 638 
and inner membrane complex marker α-IMC1, α-HA and inner membrane complex marker α-639 
MLP1. (C) α-HA and rhoptry neck/moving junction marker, α-RON4 and (D) α−HA, α-ROP47 640 
and Hoechst dye. (A-C) Scale bars represent 5 µm. (D) Scale bars represent 20 µm.   641 
 642 
Fig. 3. Deletion of TGME49_201860 and ROP48 does not affect plaque loss in response to IFNγ. 643 
(A) Monolayers of mouse embryonic fibroblasts (MEF) were infected with PruΔhxgprtΔku80, 644 
ΔTGME49_201860 or Δrop48 parasites. The plaque area was quantified after 5 days. Mean ± S.D.; 645 
n ≥ 30 plaques. (B) Quantification of the localization of IFNγ-inducible immunity-related GTPase 646 
B6 (Irgb6) on the parasite containing vacuole and of the percentage of plaque loss after 5 days on 647 
MEF stimulated with IFNγcompared with unstimulated MEF. Mean ± S.D.; n = 4 experiments. 648 
Fig. 4. Deletion of the genes encoding TGME49_201860, ROP47 and ROP48 does not affect 649 
Toxoplasma gondii virulence in mice. C57BL/6 mice were infected with 500 tachyzoites and 650 
weight and survival of mice was monitored. (A) Average percentage change in weight over time for 651 
mice i.p. infected with the indicated strains; n ≥ 4 for each strain, mean + S.D. (B) Mouse survival 652 
after i.p. infection with indicated strains; n ≥ 4 for each strain. (C) IFNγ cytokine levels in 653 
peripheral blood serum of surviving animals (n ≥ 2 for each strain) was determined by ELISA at 654 
days 7 (D7) and 30 (D30) p.i., mean ± S.D. Pru - PruΔhxgprtΔku80. Het – Heterologous control. 655 
(D) Average number of brain cysts at day 35 following i.p. infection with the indicated strains; n ≥ 656 
2 for each strain; mean ± S. D. Pru - PruΔhxgprtΔku80. Het – Heterologous control. * P = 0.0011, 657 
Student’s t-test.  658 
  659 
Supplementary Figure legends 660 
 661 
Supplementary Fig. S1. Generation of gene knockouts (KO) in Toxoplasma gondii. (A) Scheme 662 
depicting the strategy used to obtain the KO strains. The 5′ and 3′ flanking regions (FR) of our 663 
genes of interest were cloned on both sides of hypoxanthine-xanthine-guanine ribosyl transferase 664 
(HXGPRT) selection marker. The vector was linearized prior to transfection of Δku80 parasites. 665 
Following a double homologous recombination event, the genes of interest were replaced by 666 
HXGPRT. The arrows represent the primers P1, P2, P3 and P4 used to verify the gene replacement. 667 
(B) To confirm the disruption of TGME49_201860 and ROP48, PCR was performed with a 668 
forward primer upstream of the 5’ FR (P1) and a reverse primer within the HXGPRT cassette (P2). 669 
A second PCR was executed to confirm the inability to amplify the target genes (P3 and P4). The 670 
deletion of ROP47 was confirmed by western blot using an anti-ROP47 antibody on human 671 
foreskin fibroblasts (HFF) lysates that were either uninfected, infected with the parental strain or 672 
with the Δrop47 strain. Top band, indicated by *, is non-specific.  673 
 674 
Supplementary Fig. S2. Identification of new Toxoplasma rhoptry protein-encoding genes. The 675 
gene expression profiles of all expressed Toxoplasma genes were compared with the cyclical gene 676 
expression profile of rhoptry genes throughout the cell cycle by performing K-means clustering of 677 
13 duplicate samples spanning 12 h post-synchronization. The cluster with the highest number of 678 
known rhoptry protein-encoding genes is shown. Genes analyzed in detail in this report are 679 
highlighted. The complete list of genes is described in Table 2. 680 
 681 
Supplementary Fig. S3. Validation of endogenously tagged parasites. (A) Scheme depicting the 682 
strategy used to obtain the endogenously tagged strains. The hemagglutinin (HA) tag was added to 683 
the 3′ regions of genes of interest by PCR. The resulting amplicon was cloned upstream of the 3’ 684 
untranslated region (UTR) of GRA2 in a vector harboring the hypoxanthine-xanthine-guanine 685 
ribosyl transferase (HXGPRT) gene. The vector was linearized prior to transfection of Δku80 686 
parasites. By reciprocal recombination, the region of homology in the construct recombined with 687 
the homologous sequences on the chromosomal gene, introducing the HA tag to the 3′ end of the 688 
endogenous gene. The arrows represent the primers forward (F) and reverse (R) used to verify the 689 
gene replacement. GOI – gene of interest. (B) Endogenous gene tagging of seven candidate genes 690 
was confirmed by PCR, using a primer upstream of the plasmid integration site and a primer 691 
specific for the HA tag.  692 
 693 
Supplementary Fig. S4. Cellular localization of endogenously tagged genes in Toxoplasma. 694 
Representative picture of human foreskin fibroblasts (HFFs) infected with RHΔku80 expressing 695 
GFP (green) and endogenously tagged TGME49_210370, TGME49_225160, TGME49_237180 or 696 
TGME49_258360. Endogenously tagged TGME49_210370 is shown. Cells were fixed after 24 h 697 
and stained with α- hemagglutinin (α- HA, red). Scale bar represents 5 µm.  698 
 699 
Supplementary Fig. S5. The protein encoded by Toxoplasma gene TGME49_232020 is most 700 
likely processed. Western blot of RHΔhxgprtΔku80 and RHΔku80 with hemagglutinin (HA)-tagged 701 
TGME49_232020 lysates with α-HA shows migration of TGME49_232020-HA at ~ 40 kDa, 702 
whereas its predicted size is ~ 135 kDa. Blotting for the major surface antigen of Toxoplasma, 703 
SAG-1, was used as a loading control. 704 
 705 
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Table 1. Primers used in this study. 
Gene ID Forward primer Reverse primer 	  
Primers used for gene tagging (5'-3')  
TGME49_201860 CACCTCGCGACCACCTGCGTTTTGA TTACGCGTAGTCCGGGACGTCGTACGGGTAGAGTTCAGCGAAAGCACCTGC 
TGME49_210370 CACCACAGCCCGTTACGTCTTGCGAC TTACGCGTAGTCCGGGACGTCGTACGGGTAAACGGAGGGAAGAAACGGGG 
TGME49_218270 CACCGGCTGGAGATTTTTCCCCGGAACT TTACGCGTAGTCCGGGACGTCGTACGGGTAAGCCGGACTTGCAGAAGGCAC 
TGME49_225160 CACCCCATGCTTCTGTTCGCAGAAAT TTACGCGTAGTCCGGGACGTCGTACGGGTATGAATCCTTGAAACTGCGAATC 
TGME49_232020 CACCTGGCTCTCCAGCCGCGGCGATT TTACGCGTAGTCCGGGACGTCGTACGGGTATCGTCGCCGGCGCCTTCCGC 
TGME49_237180 CACCAGAAACCGCTGCTGAGGAATGG TTACGCGTAGTCCGGGACGTCGTACGGGTACATAAGAAATTTTATTTTATGGAGGCG 
TGME49_258360 CACCGCGGTGTTCGTCAGGATCTGCT TTACGCGTAGTCCGGGACGTCGTACGGGTACCCGTTAAGATGCGCAACGAC 
	  
TGME49_261740 CACCACAAAACGGGGAGCA  TTACGCGTAGTCCGGGACGTCGTACGGGTACGGTCTTTTTCCACCTTTCACACG 	  
	   	   	   	   	  
Primers used for gene knock-out (5'-3') 	   	   	  
TGME49_201860 GGGGACAAGTTTGTACAAAAAAGCAGGCTTATGCTTCGTACGACACCAACG GGGGACAACTTTGTATAGAAAAGTTGTGGCTAATGTATCCACGTGG 
	  
TGME49_201860 GGGGACAACTTTGTATAATAAAGTTGCTGAGGTCCAAGCAGCACCGAA GGGGACCACTTTGTACAAGAAAGCTGGGTAGAGAGAGTCGGGTTCGTTCG 	  
TGME49_218270 GGGGACAAGTTTGTACAAAAAAGCAGGCTTAAAGACCTCTCGCCTCGGATT GGGGACAACTTTGTATAGAAAAGTTGCTTAGGCTAAGTGTTGGAGC 
	  
TGME49_218270 GGGGACAACTTTGTATAATAAAGTTGCTCTAGTCGTCTCGGATGATGG GGGGACCACTTTGTACAAGAAAGCTGGGTATGTCGCTGGAGGATTCATGG 	  
TGME49_261740 GGGGACAAGTTTGTACAAAAAAGCAGGCTGCTTAGTAACCTGCGGATACACTTC GGGGACAACTTTGTATAGAAAAGTTGGGTGGACCGCCGAACATCATTGTTTC 
	  
TGME49_261740 GGGGACAACTTTGTATAGAAAAGTTGGGTGGACCGCCGAACATCATTGTTTC GGGGACCACTTTCTTGTACAAAGTGGTGGTAAAGGGCATGTTTTGACACGGG 	  
	   	   	   	   	  
 P1 P2 P3 P4 
TGME49_201860 CGTGACTTGAAATGCAGTCC GATCCAGACGTCTTCAATGC CACCTCGCGACCACCTGCGTTTTGA TTACGCGTAGTCCGGGACGTCGTACGGGTAGAGTTCAGCGAAAGCACCTGC 
TGME49_218270 CACTTCGACTGACATCTCAG GATCCAGACGTCTTCAATGC CACCGGCTGGAGATTTTTCCCCGGAACT TTACGCGTAGTCCGGGACGTCGTACGGGTAAGCCGGACTTGCAGAAGGCAC 
     
Primers used for generation of recombinant ROP47 peptide antigen (5'-3') 	   	   	  
TGME49_261740 CACCATTTGTCTCGCCGC CTTTCTTTTTCGACCTTTCACACG 
	  	  
Table 2. Toxoplasma genes in the rhoptry cluster. 
                  
Cell Cycle 
Microarray 
RMA 
Probeset_id ToxoDB V8_ID Product Description Subcellular localization Reference Confirmed Exons 
Transmembrane 
Domains 
Predicted 
Signal 
Peptide 
Max Min 
20.m08222 TGME49_203990 rhoptry protein ROP12 (ROP12) RHOPTRY Bradley et al., 2005 Confirmed 3 1 Yes 12.0 7.7 
20.m03896 TGME49_205250 rhoptry protein ROP18 (ROP18) RHOPTRY Taylor et al., 2006 Confirmed 1 1 Yes 13.8 10.6 
27.m00091 TGME49_211290 rhoptry protein ROP15 (ROP15) RHOPTRY Bradley et al., 2005 Confirmed 6 0 Yes 12.7 8.9 
33.m02185 TGME49_214080 toxofilin RHOPTRY Bradley et al., 2005 Confirmed 1 1 Yes 12.2 8.9 
33.m01398 TGME49_215775 rhoptry protein ROP8 (ROP8) RHOPTRY Beckers et al., 1997 Confirmed 1 1 Yes 13.0 9.4 
42.m00026 TGME49_223920 rhoptry neck protein RON3 (RON3) RHOPTRY Bradley et al., 2005 Confirmed 21 1 Yes 12.3 7.9 
42.m03584 TGME49_227810 rhoptry kinase family protein ROP11 (incomplete catalytic triad) (ROP11) RHOPTRY Bradley et al., 2005 Confirmed 1 0 Yes 13.1 9.0 
44.m06355 TGME49_229010 rhoptry neck protein RON4 (RON4) RHOPTRY Bradley et al., 2005 Confirmed 20 0 Yes 11.8 7.7 
44.m00026 TGME49_230350 rhoptry neck protein RON11 (RON11) RHOPTRY Beck et al., 2013 Confirmed 16 4  10.4 6.5 
49.m03277 TGME49_242240 rhoptry kinase family protein ROP19A (ROP19A) RHOPTRY Peixoto et al., 2010 Confirmed 1 0 Yes 10.7 7.4 
52.m01543 TGME49_252360 rhoptry kinase family protein ROP24 (incomplete catalytic triad) (ROP24) RHOPTRY Peixoto et al., 2010 Confirmed 1 0 Yes 11.8 8.0 
55.m04748 TGME49_258230 rhoptry kinase family protein ROP20 (ROP20) RHOPTRY Peixoto et al., 2010 Confirmed 1 1 Yes 10.1 6.5 
55.m08191 TGME49_258580 rhoptry protein ROP17 (ROP17) RHOPTRY Peixoto et al., 2010 Confirmed 1 0 Yes 13.1 9.8 
55.m00092 TGME49_258660 rhoptry protein ROP6 (ROP6) RHOPTRY Sohn et al., 1999 Confirmed 5 1 Yes 13.3 9.5 
55.m00167 TGME49_261750 rhoptry neck protein RON10 (RON10) RHOPTRY Lamarque et al., 2012 Confirmed 7 0  11.3 6.7 
55.m08219 TGME49_262730 rhoptry protein ROP16 (ROP16) RHOPTRY Bradley et al., 2005 Confirmed 1 0 Yes 11.9 8.5 
59.m03479 TGME49_269885 rhoptry metalloprotease toxolysin TLN1 (TLN1) RHOPTRY Hajagos et al., 2011 Confirmed 12 1 Yes 11.6 6.9 
74.m00767 TGME49_282055 protein phosphatase PP2C-hn (PP2CHN) RHOPTRY Gilbert et al., 2007 Confirmed 13 0  11.5 6.9 
80.m02343 TGME49_291960 rhoptry kinase family protein ROP40 (incomplete catalytic triad) (ROP40) RHOPTRY Peixoto et al., 2010 Confirmed 3 0 Yes 13.1 9.2 
83.m02145 TGME49_295110 rhoptry protein ROP7 (ROP7) RHOPTRY Hajj et al., 2006 Confirmed 1 1 Yes 12.7 8.6 
113.m00009 TGME49_297960 rhoptry neck protein RON6 (RON6) RHOPTRY Proellocks et al., 2006 Confirmed 10 1 Yes 11.5 7.0 
129.m00252 TGME49_299060 sodium/hydrogen exchanger NHE2 RHOPTRY Karasov et al., 2005 Confirmed 12 13  10.4 6.5 
145.m00331 TGME49_300100 rhoptry neck protein RON2 (RON2) RHOPTRY Bradley et al., 2005 Confirmed 10 3 Yes 11.4 6.5 
541.m00141 TGME49_306060 rhoptry neck protein RON8 (RON8) RHOPTRY Straub et al., 2009 Confirmed 15 1 Yes 11.9 7.0 
551.m00238 TGME49_308090 rhoptry protein ROP5 (ROP5) RHOPTRY Bradley et al., 2005 Confirmed 1 0 Yes 13.5 10.2 
583.m09207 TGME49_308810 rhoptry neck protein RON9 (RON9) RHOPTRY Lamarque et al., 2012 Confirmed 9 1  10.8 6.5 
583.m00003 TGME49_309590 rhoptry protein ROP1 (ROP1) RHOPTRY Ossorio et al., 1992 Confirmed 1 0 Yes 12.6 9.4 
583.m00597 TGME49_310010 rhoptry neck protein RON1 (RON1) RHOPTRY Bradley et al., 2005 Confirmed 5 1 Yes 11.3 6.8 
583.m00636 TGME49_311470 rhoptry neck protein RON5 (RON5) RHOPTRY Straub et al., 2009 Confirmed 38 0 Yes 12.3 7.6 
583.m00692 TGME49_315220 rhoptry protein ROP14 (ROP14) RHOPTRY Bradley et al., 2005 Confirmed 11 11  10.9 6.5 
583.m05686 TGME49_315490 rhoptry protein ROP10 (ROP10) RHOPTRY Bradley et al., 2005 Confirmed 1 0 Yes 11.1 6.6 
49.m05689 TGME49_242118 myosin-light-chain kinase RHOPTRY Peixoto et al., 2010  1 1  10.8 6.5 
20.m00331 TGME49_202200 hypothetical protein RHOPTRY Bradley et al., 2005  7 0  12.0 7.9 
27.m00846 TGME49_211260 rhoptry kinase family protein ROP26 (incomplete catalytic triad) (ROP26) RHOPTRY Peixoto et al., 2010  2 0  12.7 9.8 
41.m01337 TGME49_222100 hypothetical protein RHOPTRY Bradley et al., 2005  1 0 Yes 11.0 6.5 
49.m03276 TGME49_242230 rhoptry kinase family protein ROP29 (ROP29) RHOPTRY Peixoto et al., 2010  1 1  10.8 6.9 
49.m03399 TGME49_244250 hypothetical protein RHOPTRY Bradley et al., 2005  4 0  11.2 6.9 
52.m01529 TGME49_252200 Toxoplasma palmitoyl acyltransferase TgDHHC7 RHOPTRY Beck et al., 2013  8 4  10.1 6.5 
52.m01582 TGME49_253370 hypothetical protein (RON4L1) RHOPTRY Boothroyd and Dubremetz, 2008  30 0 Yes 10.0 6.5 
55.m04788 TGME49_258800 rhoptry kinase family protein ROP31 (ROP31) RHOPTRY Peixoto et al., 2010  1 1 Yes 10.0 6.9 
55.m05020 TGME49_262920 trypsin domain-containing protein RHOPTRY Bradley et al., 2005  11 1 Yes 9.8 6.5 
83.m01271 TGME49_294560 rhoptry kinase family protein ROP37 (incomplete catalytic triad) (ROP37) RHOPTRY Peixoto et al., 2010  1 0 Yes 10.6 6.5 
83.m01285 TGME49_294790 hypothetical protein RHOPTRY Bradley et al., 2005  1 0  13.0 9.7 
113.m00755 TGME49_297070 hypothetical protein RHOPTRY Bradley et al., 2005  2 0 Yes 12.6 8.2 
583.m00694 TGME49_315210 rhoptry protein, putative (ROP14B) RHOPTRY Reid et al., 2012  11 7  10.7 6.5 
20.m00355 TGME49_201520 protein phosphatase 2C domain-containing protein    9 0 Yes 11.0 6.6 
20.m05880 TGME49_201520 protein phosphatase 2C domain-containing protein    9 0 Yes 11.0 6.5 
20.m03673 TGME49_201760 hypothetical protein    4 0  10.5 6.5 
20.m03682 TGME49_201860 hypothetical protein    2 1 Yes 13.3 9.8 
20.m03718 TGME49_202420 hypothetical protein    2 1  9.2 6.5 
20.m00003 TGME49_202500 GAPM1a    4 6  13.7 10.2 
20.m03760 TGME49_203010 aurora kinase    1 0  9.9 6.5 
20.m05981 TGME49_203930 hypothetical protein    6 5  10.6 6.6 
20.m03880 TGME49_204880 hypothetical protein    1 0 Yes 9.3 6.5 
20.m03902 TGME49_205330 hypothetical protein    2 8  12.7 8.6 
20.m03905 TGME49_205360 hypothetical protein    20 2 Yes 9.7 6.5 
20.m03977 TGME49_206710 hypothetical protein    5 0  8.5 6.5 
25.m01833 TGME49_208910 hypothetical protein    3 0  9.2 6.5 
25.m01852 TGME49_209170 hypothetical protein    1 0 Yes 9.6 6.5 
25.m01855 TGME49_209200 hypothetical protein    12 0  9.0 6.5 
25.m01859 TGME49_209250 hypothetical protein    7 1  10.8 7.8 
26.m00235 TGME49_210270 hypothetical protein    3 0  10.1 7.6 
26.m00242 TGME49_210370 hypothetical protein    1 0 Yes 12.2 8.2 
26.m00370 TGME49_210420 hypothetical protein    1 1  11.3 7.1 
27.m00828 TGME49_210820 hypothetical protein    3 10  9.3 6.5 
28.m00429 TGME49_211850 hypothetical protein    3 0  11.8 9.1 
31.m00934 TGME49_212980 hypothetical protein    2 1  11.8 8.6 
33.m02670 TGME49_214400 hypothetical protein    2 0  10.7 6.7 
35.m00004 TGME49_216080 apical complex lysine methyltransferase    4 0  11.3 8.3 
35.m00895 TGME49_216620 EF hand domain-containing protein    39 7  9.0 6.5 
37.m00748 TGME49_217520 hypothetical protein    2 0 Yes 12.5 8.8 
38.m01037 TGME49_218240 hypothetical protein    2 1 Yes 9.6 6.5 
38.m01040 TGME49_218270 hypothetical protein    1 8 Yes 12.7 8.4 
41.m01283 TGME49_221250 hypothetical protein    8 0  9.8 6.5 
41.m00036 TGME49_221620 beta-tubulin, putative    4 0  13.1 9.7 
41.m01316 TGME49_221675 hypothetical protein    9 1 Yes 8.9 6.5 
42.m03399 TGME49_225020 hypothetical protein    4 0  9.5 6.5 
42.m03409 TGME49_225160 hypothetical protein    1 2 Yes 11.5 7.8 
42.m07438 TGME49_225200 hypothetical protein    33 0 Yes 9.2 6.5 
42.m00061 TGME49_225320 hypothetical protein    5 0 Yes 10.8 6.5 
42.m00060 TGME49_225330 hypothetical protein    6 0 Yes 9.8 6.5 
42.m03456 TGME49_225860 hypothetical protein    4 0  9.8 6.5 
42.m03481 TGME49_226220 
alveolin domain containing 
intermediate filament IMC9 
(ALV6/IMC9)    
9 0  9.7 6.5 
42.m00093 TGME49_227000 hypothetical protein    16 0  9.9 6.5 
44.m02549 TGME49_229500 hypothetical protein    2 3  9.8 6.6 
44.m02600 TGME49_230480 hypothetical protein    1 2  11.4 7.5 
44.m02630 TGME49_231000 START domain-containing protein    18 1  9.0 6.5 
44.m02636 TGME49_231070 protein kinase    1 0  10.8 6.8 
44.m02644 TGME49_231160 hypothetical protein    3 0  12.7 9.5 
44.m02678 TGME49_231840 hypothetical protein    6 0  9.7 6.5 
44.m02696 TGME49_232020 hypothetical protein    2 1  8.8 6.5 
44.m02714 TGME49_232260 hypothetical protein    3 3  10.0 6.5 
44.m02750 TGME49_232780 hypothetical protein    8 0  9.5 6.5 
46.m01616 TGME49_234540 hypothetical protein    7 9  10.2 6.5 
46.m02875 TGME49_235130 transmembrane protein    4 0 Yes 9.3 6.5 
46.m01643 TGME49_235380 hypothetical protein    11 0  8.9 6.5 
46.m01716 TGME49_236860 haloacid dehalogenase family hydrolase domain-containing protein    2 12  9.8 6.5 
46.m01722 TGME49_236960 transporter, major facilitator family protein    10 10  10.8 6.8 
46.m01740 TGME49_237180 hypothetical protein    1 0 Yes 12.1 7.8 
46.m01741 TGME49_237190 hypothetical protein    4 0  9.7 6.5 
46.m01743 TGME49_237210 Tyrosine kinase-like (TKL) protein    4 0  10.2 6.5 
49.m03087 TGME49_238150 hypothetical protein    1 8  12.7 10.2 
49.m03179 TGME49_239830 TBC domain-containing protein    13 0  10.7 6.5 
49.m03213 TGME49_240460 AP2 domain transcription factor AP2VI-1 (AP2VI1)    2 0  10.9 6.8 
49.m07198 TGME49_240730 hypothetical protein    2 4  9.0 6.5 
49.m07245 TGME49_241000 hypothetical protein    1 4  11.0 7.0 
49.m03332 TGME49_243200 hypothetical protein    5 0  12.2 6.6 
49.m00056 TGME49_243690 hypothetical protein    4 1  12.1 8.0 
49.m03388 TGME49_244080 hypothetical protein    3 1 Yes 10.7 6.5 
49.m03412 TGME49_244470 hypothetical protein    8 0  10.0 7.0 
50.m03074 TGME49_245550 hypothetical protein    1 4 Yes 10.0 6.5 
50.m03107 TGME49_246182 hypothetical protein       10.1 7.2 
50.m03131 TGME49_246710 hypothetical protein    1 3  9.0 6.5 
50.m03132 TGME49_246720 hypothetical protein    1 0  10.2 7.2 
50.m03154 TGME49_247195 microneme protein MIC15 (MIC15)    42 1 Yes 9.8 6.5 
50.m03253 TGME49_248690 hypothetical protein    7 0  9.4 6.8 
50.m03302 TGME49_249440 hypothetical protein    2 0  9.9 6.5 
50.m03315 TGME49_249570 hypothetical protein    20 1 Yes 11.4 6.8 
52.m01567 TGME49_253140 hypothetical protein    3 0  9.3 6.5 
52.m01583 TGME49_253380 AP2 domain transcription factor AP2III-2 (AP2III2)    1 0  10.5 6.8 
52.m01598 TGME49_253600 hypothetical protein    11 0  9.6 6.5 
52.m01644 TGME49_254290 hypothetical protein    1 0  9.0 6.5 
55.m04629 TGME49_255700 hypothetical protein    6 0  9.7 6.5 
55.m08188 TGME49_256030 hypothetical protein    6 0  12.1 7.6 
55.m04752 TGME49_258360 hypothetical protein    7 0 Yes 11.6 7.0 
55.m00096 TGME49_258700 transporter, major facilitator family protein    12 11  9.3 6.5 
55.m04796 TGME49_258900 hypothetical protein    4 0  9.3 6.5 
55.m04843 TGME49_259700 hypothetical protein    2 3  11.1 6.9 
55.m00144 TGME49_260820 IMC sub-compartment protein ISP1 (ISP1)    3 0  12.0 8.5 
55.m04955 TGME49_261740 hypothetical protein    1 1 Yes 14.2 11.9 
57.m01689 TGME49_264600 hypothetical protein    2 4  12.2 7.5 
57.m01720 TGME49_265080 Tubulin-tyrosine ligase family protein    12 0  9.6 6.5 
57.m01755 TGME49_265650 protein phosphatase 2C domain-containing protein    1 0 Yes 9.7 6.5 
57.m01783 TGME49_266300 hypothetical protein    2 0  12.3 8.0 
57.m01792 TGME49_266435 hypothetical protein    34 0  9.4 6.5 
57.m01834 TGME49_267070 aquaporin 2    1 11  11.6 7.7 
59.m03403 TGME49_268760 hypothetical protein       12.2 8.6 
59.m00087 TGME49_268870 tetratricopeptide repeat-containing protein    10 0  10.3 6.5 
59.m00092 TGME49_269330 hypothetical protein    10 0  10.1 6.6 
59.m00029 TGME49_269340 hypothetical protein    4 1  11.4 6.9 
59.m03542 TGME49_270890 hypothetical protein    3 0  9.4 6.5 
59.m00038 TGME49_271270 hypothetical protein    10 1  11.2 7.0 
59.m03707 TGME49_273860 hypothetical protein    1 0  11.0 8.2 
64.m00327 TGME49_275670 
alveolin domain containing 
intermediate filament IMC15 
(ALV5/IMC15)    
9 0  10.8 6.5 
64.m00582 TGME49_276130 cathepsin CPC2 (CPC2)    10 0 Yes 9.7 6.5 
65.m01152 TGME49_278130 hypothetical protein    14 0  9.3 6.5 
65.m01964 TGME49_278510 protein phosphatase 2C domain-containing protein    10 1 Yes 11.1 7.3 
65.m02537 TGME49_278920 hypothetical protein    5 6  9.5 6.5 
69.m00143 TGME49_279420 hypothetical protein    1 0  11.3 6.5 
72.m00385 TGME49_280480 EF hand domain-containing protein    1 4  11.5 6.8 
72.m00685 TGME49_280670 hypothetical protein    7 10 Yes 11.3 6.7 
74.m00455 TGME49_282070 hypothetical protein    9 0  10.8 6.5 
74.m00465 TGME49_282210 AP2 domain transcription factor AP2VIIa-8 (AP2VIIA8)    2 0  9.3 6.5 
76.m01597 TGME49_285290 hypothetical protein    1 3 Yes 10.3 6.5 
76.m01608 TGME49_285650 hypothetical protein    2 0  8.9 6.5 
76.m01626 TGME49_285870 SAG-related sequence SRS20A (SRS20A)    2 1 Yes 12.8 8.7 
76.m01662 TGME49_286500 hypothetical protein    1 10  9.9 6.5 
80.m02122 TGME49_287970 hypothetical protein    3 0  10.4 6.5 
80.m02181 TGME49_288950 AP2 domain transcription factor AP2IX-4 (AP2IX4)    1 0  9.7 6.5 
80.m03982 TGME49_289150 hypothetical protein    5 1  9.4 6.5 
80.m03946 TGME49_289970 hypothetical protein    3 0  11.7 9.3 
83.m01220 TGME49_293540 hypothetical protein    6 0  10.3 6.5 
83.m01311 TGME49_295100 hypothetical protein    4 0  9.5 6.9 
86.m00370 TGME49_295420 hypothetical protein    9 0  10.4 7.0 
86.m00377 TGME49_295620 hypothetical protein    4 0  9.7 6.5 
113.m01286 TGME49_298010 hypothetical protein    52 0  9.1 6.5 
145.m00603 TGME49_300220 hypothetical protein    15 4 Yes 9.4 6.5 
145.m00607 TGME49_300360 ADP/ATP translocase    6 2  9.5 6.5 
162.m00326 TGME49_301420 hypothetical protein    7 0  11.8 7.5 
541.m00127 TGME49_305250 hypothetical protein    6 6  10.5 7.1 
541.m01166 TGME49_305270 hypothetical protein    6 0 Yes 10.2 6.5 
541.m00131 TGME49_305510 hypothetical protein    7 0 Yes 11.9 7.9 
541.m01185 TGME49_305590 ABC transporter transmembrane region domain-containing protein    9 9  9.5 6.5 
542.m00226 TGME49_307020 hypothetical protein    3 0  9.4 6.5 
551.m00232 TGME49_308010 hypothetical protein    1 0  9.0 6.5 
583.m05275 TGME49_309160 IgA-specific metalloendopeptidase    1 0 Yes 10.4 6.5 
583.m09102 TGME49_310240 hypothetical protein    1 2  10.3 6.5 
583.m11449 TGME49_310740 hypothetical protein    2 7  9.3 6.5 
583.m00659 TGME49_311800 endonuclease/exonuclease/phosphatase family protein    6 0  9.1 6.6 
583.m00645 TGME49_312150 hypothetical protein    6 1  11.7 7.6 
583.m09217 TGME49_313780 hypothetical protein    1 0  11.1 7.3 
583.m09134 TGME49_314260 hypothetical protein    1 1  12.1 8.2 
583.m05709 TGME49_315780 myosin regulatory light chain, putative    7 0  11.5 8.6 
583.m05738 TGME49_316260 hypothetical protein    2 7  12.3 8.1 
583.m09158 TGME49_316280 transporter, major facilitator family protein    4 8  11.7 7.3 
583.m05758 TGME49_316540 IMC sub-compartment protein ISP3 (ISP3)    1 0  11.1 8.0 
611.m00052 TGME49_317705 enoyl-CoA hydratase/isomerase family protein    8 0  10.5 7.2 
641.m01483 TGME49_318470 AP2 domain transcription factor AP2IV-4 (AP2IV4)    1 0  9.3 6.5 
641.m00181 TGME49_320740 hypothetical protein    5 1 Yes 11.7 8.6 
645.m00324 TGME49_321600 hypothetical protein    7 0  9.6 6.5 
Genes highlighted in grey were further characterized in this study. 
RMA, Robust Multi-array Average 	  
Table 3. Characteristics of candidate genes      
Candidate gene 
ToxoDB V8 ID Alias 
Signal 
peptide 
TM 
domains 
Conserved 
domains 
Paralogue (% protein 
identity) 
Paralogue 
present in 
rhoptry cluster 
Homologue in Neospora 
caninum (% protein 
identity) 
TGME49_201860 - Yes 1 - TGME49_301390 (31%) No NCLIV_022900 (75%) 
TGME49_218270 ROP48 Yes 8 - TGME49_209810 (29%) No NCLIV_061950 (71%) 
TGME49_232020 RON12 Yes, in GT1 and CEP 1 - TGME49_244726 (27%) No NCLIV_032020 (59%) 
TGME49_261740 ROP47 Yes 1 - -   NCLIV_025740 (43%) 	  
Supplementary Table S1. Rhoptry encoding genes expressed above background and present on the Toxoplasma array	  
ToxoDB V8_ID Product Description In Rhoptry Cluster Reference Confirmed 
TGME49_203990 rhoptry protein ROP12 (ROP12) Yes Bradley et al., 2005 Confirmed 
TGME49_205250 rhoptry protein ROP18 (ROP18) Yes Taylor et al,. 2006 Confirmed 
TGME49_211290 rhoptry protein ROP15 (ROP15) Yes Bradley et al., 2005 Confirmed 
TGME49_214080 toxofilin Yes Bradley et al., 2005 Confirmed 
TGME49_215775 rhoptry protein ROP8 (ROP8) Yes Beckers et al., 1997 Confirmed 
TGME49_223920 rhoptry neck protein RON3 (RON3) Yes Bradley et al., 2005 Confirmed 
TGME49_227810 rhoptry kinase family protein ROP11 (incomplete catalytic triad) (ROP11) Yes Bradley et al., 2005 Confirmed 
TGME49_229010 rhoptry neck protein RON4 (RON4) Yes Bradley et al., 2005 Confirmed 
TGME49_230350 rhoptry neck protein RON11 (RON11) Yes Beck et al., 2013 Confirmed 
TGME49_242240 rhoptry kinase family protein ROP19A (ROP19A) Yes Peixoto et al., 2010 Confirmed 
TGME49_252200 Toxoplasma palmitoyl acyltransferase TgDHHC7 Yes Beck et al., 2013 Confirmed 
TGME49_252360 rhoptry kinase family protein ROP24 (incomplete catalytic triad) (ROP24) Yes Peixoto et al., 2010 Confirmed 
TGME49_258230 rhoptry kinase family protein ROP20 (ROP20) Yes Peixoto et al., 2010 Confirmed 
TGME49_258580 rhoptry protein ROP17 (ROP17) Yes Peixoto et al., 2010 Confirmed 
TGME49_258660 rhoptry protein ROP6 (ROP6) Yes Sohn et al., 1999 Confirmed 
TGME49_261750 rhoptry neck protein RON10 (RON10) Yes Lamarque et al., 2012 Confirmed 
TGME49_262730 rhoptry protein ROP16 (ROP16) Yes Bradley et al., 2005 Confirmed 
TGME49_282055 protein phosphatase PP2C-hn (PP2CHN) Yes Gilbert et al., 2007 Confirmed 
TGME49_291960 rhoptry kinase family protein ROP40 (incomplete catalytic triad) (ROP40) Yes Peixoto et al., 2010 Confirmed 
TGME49_295110 rhoptry protein ROP7 (ROP7) Yes Hajj et al., 2006 Confirmed 
TGME49_297960 rhoptry neck protein RON6 (RON6) Yes Proellocks et al., 2006 Confirmed 
TGME49_299060 sodium/hydrogen exchanger NHE2 (ROP) Yes Karasov et al., 2005 Confirmed 
TGME49_300100 rhoptry neck protein RON2 (RON2) Yes Bradley et al., 2005 Confirmed 
TGME49_306060 rhoptry neck protein RON8 (RON8) Yes Straub et al., 2009 Confirmed 
TGME49_308090 rhoptry protein ROP5 (ROP5) Yes Bradley et al., 2005 Confirmed 
TGME49_308810 rhoptry neck protein RON9 (RON9) Yes Lamarque et al., 2012 Confirmed 
TGME49_309590 rhoptry protein ROP1 (ROP1) Yes Ossorio et al., 1992 Confirmed 
TGME49_310010 rhoptry neck protein RON1 (RON1) Yes Bradley et al., 2005 Confirmed 
TGME49_311470 rhoptry neck protein RON5 (RON5) Yes Straub et al., 2009 Confirmed 
TGME49_315220 rhoptry protein ROP14 (ROP14) Yes Bradley et al., 2005 Confirmed 
TGME49_315490 rhoptry protein ROP10 (ROP10) Yes Bradley et al., 2005 Confirmed 
TGME49_242118 myosin-light-chain kinase Yes Peixoto et al., 2010  
TGME49_202200 hypothetical protein Yes Bradley et al., 2005  
TGME49_211260 rhoptry kinase family protein ROP26 (incomplete catalytic triad) (ROP26) Yes Peixoto et al., 2010  
TGME49_222100 hypothetical protein Yes Bradley et al., 2005  
TGME49_242230 rhoptry kinase family protein ROP29 (ROP29) Yes Peixoto et al., 2010  
TGME49_244250 hypothetical protein Yes Bradley et al., 2005  
TGME49_253370 hypothetical protein (RON4L1) Yes Boothroyd and Dubremetz, 2008  
TGME49_258800 rhoptry kinase family protein ROP31 (ROP31) Yes Peixoto et al., 2010  
TGME49_262920 trypsin domain-containing protein  Yes Bradley et al., 2005  
TGME49_294560 rhoptry kinase family protein ROP37 (incomplete catalytic triad) (ROP37) Yes Peixoto et al., 2010  
TGME49_294790 hypothetical protein Yes Bradley et al., 2005  
TGME49_297070 hypothetical protein Yes Bradley et al., 2005  
TGME49_315210 rhoptry protein, putative (ROP14B) Yes Reid et al., 2012  
TGME49_243730 rhoptry protein ROP9 (ROP9) No Reichman et al., 2002 Confirmed 
TGME49_261440 ARM repeats containing protein TgARO No Cabrera et al., 2012 Confirmed 
TGME49_262050 rhoptry kinase family protein ROP39 (ROP39) No Peixoto et al., 2010 Confirmed 
TGME49_269885 rhoptry metalloprotease toxolysin TLN1 (TLN1) No Hajagos et al., 2011  Confirmed 
TGME49_314500 subtilisin SUB2 (SUB2)  No Miller et al., 2003  Confirmed 
TGME49_242110 rhoptry kinase family protein ROP38 (ROP38) No Peixoto et al., 2010 Confirmed 
TGME49_314250 bradyzoite rhoptry protein BRP1 (BRP1) No Schwarz et al., 2005   
TGME49_201130 rhoptry kinase family protein ROP33 (ROP33) No Peixoto et al., 2010  
TGME49_202780 rhoptry kinase family protein ROP25 (ROP25) No Peixoto et al., 2010  
TGME49_209985 cAMP-dependent protein kinase No Bradley et al., 2005  
TGME49_227010 rhoptry kinase family protein ROP30 (ROP30) No Peixoto et al., 2010  
TGME49_230470 rhoptry kinase family protein ROP46, putative No Peixoto et al., 2010  
TGME49_239600 rhoptry kinase family protein ROP23 (incomplete catalytic triad) (ROP23) No Peixoto et al., 2010  
TGME49_240090  rhoptry kinase family protein ROP34, putative No Peixoto et al., 2010  
TGME49_249470 rhoptry kinase family protein, truncated (incomplete catalytic triad) No Peixoto et al., 2010  
TGME49_266100  rhoptry kinase family protein ROP41 (ROP41) No Peixoto et al., 2010  
TGME49_270320 protein phosphatase 2C domain-containing protein  No Bradley et al., 2005  
TGME49_270920 rhoptry kinase family protein ROP32 (ROP32) No Peixoto et al., 2010  
TGME49_281675 rhoptry kinase family protein ROP45 (ROP45) No Peixoto et al., 2010  
TGME49_294400 rhoptry neck protein RON2L1 (RON2L1) No Fritz et al., 2012  
TGME49_304740 rhoptry kinase family protein ROP35 (ROP35) No Peixoto et al., 2010  
TGME49_315940 rhoptry protein, putative No ToxoDB.org   	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